January 25, 2023
For the first time, researchers at UC San Diego have created an atomic-level computer model of the H1N1 virus that reveals new vulnerabilities, suggesting possible strategies for the design of future vaccines and antivirals against influenza.
October 12, 2018
…at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.
November 2, 2023
David Marchick ‘88, author of The Peaceful Transfer of Power: An Oral History of America’s Presidential Transitions, shares his perspective on how we can use history to help us understand conflicts of the present day.
September 26, 2022
Researchers study human milk, pregnancy and COVID-19. This story appeared in the Fall 2022 issue of UC San Diego Magazine.
November 2, 2023
Rommie Amaro, professor of molecular biology at UC San Diego, and her team use computers to investigate biological systems. Last year, their atomic-level computational model of the H1N1 influenza virus revealed vulnerabilities that could lead to more effective and longer-lasting flu vaccines.
September 3, 2019
CARB-X, an international funder of efforts to fight antimicrobial resistance, is awarding up to $15 million to develop a strep throat vaccine based on original research at UC San Diego.
September 2, 2020
UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.
September 9, 2014
…develop therapeutics and a vaccine against the deadly Ebola virus disease (EVD) requires a complex understanding of the microorganism and its relationship within the host, especially the immune response. Adding to the challenge, EVD can be caused by any one of five known species within the genus Ebolavirus (EBOV), in…
September 1, 2021
A study measured effectiveness of COVID-19 mRNA vaccines among health workers, most notably during the emergence of delta virus variant and coincident with end of state’s mask mandate, finding protection waned over time, dropping sharply 6-8 months after full vaccination.
January 27, 2016
In response to low national vaccination rates for the human papillomavirus (HPV), Moores Cancer Center at UC San Diego Health has joined 68 National Cancer Institute (NCI)-designated cancer centers in issuing a statement urging for increased HPV vaccination.